Safety and effectiveness of apixaban versus warfarin for acute venous thromboembolism in patients with end‐stage kidney disease: A national cohort study

BACKGROUND: Patients with end‐stage kidney disease (ESKD) are at significantly increased risk for both thrombosis and bleeding relative to those with normal renal function. The optimal therapy of venous thromboembolism (VTE) in patients with ESKD is unknown. OBJECTIVE: To compare the safety and effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellenbogen, Michael I., Ardeshirrouhanifard, Shirin, Segal, Jodi B., Streiff, Michael B., Deitelzweig, Steven B., Brotman, Daniel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804323/
https://www.ncbi.nlm.nih.gov/pubmed/35929542
http://dx.doi.org/10.1002/jhm.12926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804323/
https://www.ncbi.nlm.nih.gov/pubmed/35929542
http://dx.doi.org/10.1002/jhm.12926

Ejemplares similares